Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2

A Catania1, P Grieco, A Randazzo

  • 1Division of Internal Medicine, Ospedale Maggiore di Milano IRCCS, 20122 Milano, Italy. anna.catania@unimi.it

Insights

A novel peptide dimer, [Ac-CKPV]2, demonstrates potent antifungal activity against drug-resistant Candida species. This discovery offers a promising new therapeutic avenue for treating challenging fungal infections.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Mycology

Background:

  • Alpha-melanocyte-stimulating hormone (alpha-MSH) and its tripeptide KPV exhibit antimicrobial properties.
  • Azole-resistant Candida species pose a significant therapeutic challenge.

Purpose of the Study:

  • To design and evaluate a novel peptide dimer, [Ac-CKPV]2, for antifungal activity.
  • To investigate the structural characteristics of [Ac-CKPV]2.

Main Methods:

  • Synthesis of the peptide dimer [Ac-CKPV]2 by linking two KPV units with a Cys-Cys linker.
  • Antifungal activity testing against azole-resistant Candida species.
  • Structural analysis using 1H-NMR and computational methods (restrained mechanic and dynamic calculations).

Main Results:

  • The peptide dimer [Ac-CKPV]2 exhibited significant candidacidal effects.
  • [Ac-CKPV]2 demonstrated activity against azole-resistant Candida strains.
  • Structural studies indicated an extended backbone with a beta-turn-like conformation.

Conclusions:

  • The peptide dimer [Ac-CKPV]2 is a promising candidate for developing new antifungal therapies.
  • The structural insights into [Ac-CKPV]2 pave the way for designing novel candidacidal compounds.
  • These findings offer potential solutions for treating clinical fungal infections.